Teva Pharmaceutical Fine Chemicals S.r.l Sustainability Profile
Teva Pharmaceutical Fine Chemicals S.r.l., a subsidiary of Teva Pharmaceutical Industries Ltd., is a prominent player in the pharmaceutical fine chemicals sector. Headquartered in Italy, the company operates extensively across Europe and beyond, specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Founded in the early 20th century, Teva has achieved significant milestones, including advancements in sustainable production methods. Teva Pharmaceutical Fine Chemicals is renowned for its high-quality, cost-effective products that cater to a diverse range of therapeutic areas, including oncology and central nervous system disorders. The company’s commitment to innovation and regulatory compliance has solidified its position as a trusted partner in the pharmaceutical industry. With a strong focus on quality and sustainability, Teva continues to lead in the competitive landscape of pharmaceutical fine chemicals.
DitchCarbon Score
How does Teva Pharmaceutical Fine Chemicals S.r.l's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Teva Pharmaceutical Fine Chemicals S.r.l's score of 82 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Teva Pharmaceutical Fine Chemicals S.r.l, headquartered in Italy, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. However, the company is part of a broader corporate family, with emissions data and climate commitments cascaded from its parent organisation, Teva Pharmaceutical Industries Limited. Teva Pharmaceutical Industries Limited has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). These initiatives aim to enhance transparency and accountability in their climate commitments, although specific reduction targets for Teva Pharmaceutical Fine Chemicals S.r.l have not been detailed. As a current subsidiary of Teva Pharmaceutical Industries Limited, Teva Pharmaceutical Fine Chemicals S.r.l aligns with the overarching sustainability goals of its parent company, which includes commitments to reduce greenhouse gas emissions across all scopes. However, without specific emissions data or reduction targets available for Teva Pharmaceutical Fine Chemicals S.r.l, it is challenging to provide a comprehensive overview of their individual climate performance. In summary, while Teva Pharmaceutical Fine Chemicals S.r.l is engaged in climate initiatives through its parent company, specific emissions data and reduction targets remain undisclosed.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 438,420,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 613,541,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Teva Pharmaceutical Fine Chemicals S.r.l's Industry?
How Carbon Intensive is Teva Pharmaceutical Fine Chemicals S.r.l's Location?
Teva Pharmaceutical Fine Chemicals S.r.l's Scope 3 Categories Breakdown
Teva Pharmaceutical Fine Chemicals S.r.l's Scope 3 emissions, which decreased by 6% last year and decreased by approximately 24% since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 61% of Scope 3 emissions.
Top Scope 3 Categories
Teva Pharmaceutical Fine Chemicals S.r.l's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Teva Pharmaceutical Fine Chemicals S.r.l has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
